logo
Select company
Select metric
$ 132.75MNet Cash Flow - Investing
VS
Market
95
Sector
95
Industry
94
History
100
$ 1.73Close
$ 0.61 - $ 16.96 52-Week Range
Ticker Information

Ticker

NMRA

Company Name

NEUMORA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NEUMORA THERAPEUTICS INC - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NMRA - CF - Investing Historical data
DateNet Cash Flow - Investing
6/30/2025$ 132.75M
3/31/2025$ 123.6M
12/31/2024$ -70.56M
9/30/2024$ 41.92M
6/30/2024$ -91.25M
12/31/2023$ 64.39M
12/31/2022$ -168.01M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEUMORA THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Investing stands at $ -168.01M.
  • Over the past 5 years, NEUMORA THERAPEUTICS INC's average CF - Investing has been $ 4.69M.
  • The median CF - Investing for NEUMORA THERAPEUTICS INC during this period was $ 41.92M
  • NEUMORA THERAPEUTICS INC reached its highest CF - Investing over the past 5 years at $ 132.75M.
  • The lowest CF - Investing recorded by NEUMORA THERAPEUTICS INC in the same timeframe $ -168.01M

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

NMRA - Net Cash Flow - Investing, Last 5 years

$ -168.01M

Minimum

Dec 31, 2022

$ 132.75M

Maximum

Jun 30, 2025

$ 4.69M

Average

$ 41.92M

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.29M with a standard deviation of $ 83.34M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.17K
min$ -292.23M
max$ 241M
average$ -35.29M
median$ -6.38M
std$ 83.34M